Huihui Ye

Also affiliated with Hangzhou Dianzi University

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 30 papers. Top paper: “Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response”.

Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2344

N/A

1.2DataRank · unranked

38 citations

Stephanie M. Walker, Scott Wilkinson, Ravi A. Madan, Joanna H. Shih, Maria J. Merino +20 more

ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer

Nucleic Acids Research(2024)10.1093/nar/gkae547

N/A

0.703DataRank · unranked

36 citations

Qian Yang, Mirja Rotinen, Rongrong Huang, Hyo‐Young Kim, Brad Gallent +21 more

Decrease in stromal androgen receptor associates with androgen‐independent disease and promotes prostate cancer cell proliferation and invasion

Journal of Cellular and Molecular Medicine(2008)10.1111/j.1582-4934.2008.00279.x

N/A

0.657DataRank · unranked

79 citations

Caihong X. Li, Huihui Ye, Fei Chen, Jonathan Melamed, Yi Peng +8 more

Autocrine Canonical Wnt Signaling Primes Noncanonical Signaling through ROR1 in Metastatic Castration-Resistant Prostate Cancer

Cancer Research(2022)10.1158/0008-5472.can-21-1807

N/A

0.553DataRank · unranked

39 citations

Seiji Arai, Keshan Wang, Carla Calagua, Amanda R. Yuan, Larysa Poluben +12 more

Localized high-risk prostate cancer harbors an androgen receptor activity–low subpopulation susceptible to HER2 inhibition

Journal of Clinical Investigation(2025)10.1172/jci189900

N/A

0.172DataRank · unranked

2 citations

Anson T. Ku, Rosina T. Lis, I. King, Daniel Low, Shana Y. Trostel +26 more

A multi-resolution model for histopathology image classification and localization with multiple instance learning

Computers in Biology and Medicine(2021)10.1016/j.compbiomed.2021.104253

N/A

0DataRank · unranked

117 citations

Wenyuan Li, Anthony Sisk, Huihui Ye, William D. Wallace, William Speier +2 more

Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy

European Urology(2021)10.1016/j.eururo.2021.03.009

N/A

0DataRank · unranked

74 citations

Huihui Ye, Fatima Karzai, Stephanie A. Harmon, Nicholas T. Terrigino, David James VanderWeele +23 more

A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0121

N/A

0DataRank · unranked

48 citations

Miriam Ficial, Caroline S. Jansen, Taghreed Hirz, Luke del Balzo, Scott Wilkinson +12 more

A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes

medRxiv(2021)10.1101/2021.01.27.21250464

N/A

0DataRank · unranked

4 citations

Miriam Ficial, Caroline S. Jansen, Taghreed Hirz, Luke del Balzo, Scott Wilkinson +12 more

Reply to Alessia Cimadamore, Liang Cheng, Antonio Lopez-Beltran, Marina Scarpelli, and Rodolfo Montironi’s Letter to the Editor re: Scott Wilkinson, Huihui Ye, Fatima Karzai, et al. Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.03.009: Focus on Intraductal Carcinoma of the Prostate

European Urology(2021)10.1016/j.eururo.2021.06.002

N/A

0DataRank · unranked

1 citations

Huihui Ye, Rosina T. Lis, Adam G. Sowalsky, Scott Wilkinson

Effects of dietary omega-3 fatty acids on orthotopic prostate cancer progression, tumor associated macrophages, angiogenesis and T-cell activation—dependence on GPR120

Prostate Cancer and Prostatic Diseases(2022)10.1038/s41391-021-00440-2

N/A

0DataRank · unranked

23 citations

Susanne M. Henning, Tristan Grogan, David Elashoff, Huihui Ye, Pinchas Cohen +2 more

TMPRSS2-ERG promotes the initiation of prostate cancer by suppressing oncogene-induced senescence

Cancer Gene Therapy(2022)10.1038/s41417-022-00454-5

N/A

0DataRank · unranked

22 citations

Dongmei Li, JuanJuan Yin, Hong Pan, Huihui Ye, Joel Bowman +3 more

Improved Balanced Steady-State Free Precession Based MR Fingerprinting with Deep Autoencoders

2022 44th Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC)(2022)10.1109/embc48229.2022.9871003

N/A

0DataRank · unranked

6 citations

Huihui Ye, Bo Zhao, Hengfa Lu

A case report of multiple primary prostate tumors with differential drug sensitivity

Nature Communications(2020)10.1038/s41467-020-14657-7

N/A

0DataRank · unranked

40 citations

Stephanie A. Harmon, Nicholas T. Terrigino, Fatima Karzai, Peter A. Pinto, Ravi A. Madan +16 more

MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer

Cell Reports(2023)10.1016/j.celrep.2023.113221

N/A

0DataRank · unranked

33 citations

Jenna M. Giafaglione, Anthony E. Jones, Nicholas M. Nunley, Takao Hashimoto, Amelie M.L. Delcourt +20 more

Data from A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes

(2023)10.1158/1078-0432.c.6530387

N/A

0DataRank · unranked

0 citations

Miriam Ficial, Caroline S. Jansen, Taghreed Hirz, Luke del Balzo, Scott Wilkinson +12 more

Data from A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes

(2023)10.1158/1078-0432.c.6530387.v1

N/A

0DataRank · unranked

0 citations

Miriam Ficial, Caroline S. Jansen, Taghreed Hirz, Luke del Balzo, Scott Wilkinson +12 more

Data from Autocrine Canonical Wnt Signaling Primes Noncanonical Signaling through ROR1 in Metastatic Castration-Resistant Prostate Cancer

(2023)10.1158/0008-5472.c.6513813.v1

N/A

0DataRank · unranked

0 citations

Seiji Arai, Keshan Wang, Carla Calagua, Amanda R. Yuan, Larysa Poluben +12 more

Data from Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response

(2023)10.1158/1078-0432.c.6530054

N/A

0DataRank · unranked

0 citations

Stephanie M. Walker, Scott Wilkinson, Ravi A. Madan, Joanna H. Shih, Maria J. Merino +20 more

Data from Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response

(2023)10.1158/1078-0432.c.6530054.v1

N/A

0DataRank · unranked

0 citations

Stephanie M. Walker, Scott Wilkinson, Ravi A. Madan, Joanna H. Shih, Maria J. Merino +20 more

Localized high-risk prostate cancer harbors an androgen receptor low subpopulation susceptible to HER2 inhibition

medRxiv(2024)10.1101/2024.02.09.24302395

N/A

0DataRank · unranked

4 citations

Anson T. Ku, Rosina T. Lis, I. King, Daniel Low, Shana Y. Trostel +21 more

ELOC-Mutated Renal Cell Carcinoma is a Rare Indolent Tumor With Distinctive Genomic Characteristics

Modern Pathology(2025)10.1016/j.modpat.2025.100777

N/A

0DataRank · unranked

13 citations

Rong Rong Huang, Brian Cone, Sung‐Hae Kang, Reza Setoodeh, Anthony Sisk +5 more

Androgen deprivation–mediated activation of AKT is enhanced in prostate cancer with TMPRSS2:ERG fusion

Journal of Clinical Investigation(2025)10.1172/jci192368

N/A

0DataRank · unranked

1 citations

Sen Chen, Luigi Cecchi, Betul Ersoy-Fazlioglu, Joshua W. Russo, Seiji Arai +16 more

Observing biological spatio-angular structures and dynamics with statistical image reconstruction and polarized fluorescence microscopy

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.09.23.678164

N/A

0DataRank · unranked

0 citations

Talon Chandler, Yue Li, Atharva Agashe, Mingzhe Wei, Yijun Su +16 more

Neoadjuvant Antiandrogen Therapy With or Without MEK or SRC Inhibition for Unfavorable-risk Prostate Cancer: A Phase 2 Randomized Clinical Trial

European Urology Oncology(2025)10.1016/j.euo.2025.10.013

N/A

0DataRank · unranked

0 citations

Adam B. Weiner, Julie Livingstone, Aydin Pooli, Rong Huang, Huihui Ye +6 more

Androgen receptor inhibition induces metabolic reprogramming and increased reliance on oxidative mitochondrial metabolism in prostate cancer

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.05.31.494200

N/A

0DataRank · unranked

2 citations

Jenna M. Giafaglione, Anthony E. Jones, Nicholas M. Nunley, Takao Hashimoto, Amelie M.L. Delcourt +16 more

MEIS1 down-regulation by MYC mediates prostate cancer development through elevated HOXB13 expression and AR activity

Oncogene(2020)10.1038/s41388-020-01389-7

N/A

0DataRank · unranked

34 citations

Shana Y. Trostel, Scott Wilkinson, Nicholas T. Terrigino, S. Thomas Hennigan, Ross Lake +8 more

Nascent prostate cancer heterogeneity drives evolution and resistance to intense hormonal therapy

medRxiv(2020)10.1101/2020.09.29.20199711

N/A

0DataRank · unranked

12 citations

Huihui Ye, Fatima Karzai, Stephanie A. Harmon, Nicholas T. Terrigino, David James VanderWeele +23 more

Multiple primary prostate tumors with differential drug sensitivity.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.342

N/A

0DataRank · unranked

0 citations

Huihui Ye, Nicholas T. Terrigino, Nicole V. Carrabba, Rayann Atway, Shana Y. Trostel +14 more

EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer

Nature Cancer(2021)10.1038/s43018-021-00185-w

N/A

0DataRank · unranked

241 citations

Anjali V. Sheahan, Deborah L. Burkhart, Sylvan C. Baca, Nadia Boufaied, Yin Liu +32 more